Pro Medicus Limited
PME
Rangering i aksjer
#1597
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a... Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
Aksjekurs
$129.30
Markedsverdi
$13.51B
Endring (1 dag)
-0.17%
Endring (1 år)
-30.83%
Land
AU
Handel Pro Medicus Limited (PME)
Kategori
Healthcare
Antall utestående aksjer for Pro Medicus Limited (PME)
Antall utestående aksjer per June 2026: 104.47M
Ifølge Pro Medicus Limited sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 104.47M. Ved slutten av June 2024 hadde selskapet 104.44M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Pro Medicus Limited (PME) fra 2000 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 104.47M | -0.01% |
| 2025 | 104.48M | 0.03% |
| 2024 | 104.44M | 0.03% |
| 2023 | 104.41M | 0.09% |
| 2022 | 104.31M | 0.14% |
| 2021 | 104.17M | 0.26% |
| 2020 | 103.90M | 0.31% |
| 2019 | 103.57M | 0.37% |
| 2018 | 103.19M | 0.69% |
| 2017 | 102.49M | 1.09% |
| 2016 | 101.38M | 1.11% |
| 2015 | 100.26M | 0.00% |
| 2014 | 100.26M | 0.92% |
| 2013 | 99.35M | -0.91% |
| 2012 | 100.26M | -0.02% |
| 2011 | 100.28M | 0.00% |
| 2010 | 100.28M | 0.00% |
| 2009 | 100.28M | 0.00% |
| 2008 | 100.28M | 0.26% |
| 2007 | 100.02M | 0.02% |
| 2006 | 100.00M | 0.00% |
| 2005 | 100.00M | 0.00% |
| 2004 | 100.00M | 0.00% |
| 2003 | 100.00M | 0.00% |
| 2002 | 100.00M | 0.00% |
| 2001 | 100.00M | 0.00% |
| 2000 | 100.00M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 453.00M | 333.62% |
US
|
|
| 205.38M | 96.59% |
US
|
|
| 179.92M | 72.22% |
US
|
|
| 129.98M | 24.42% |
US
|
|
| - | - |
US
|
